The End of Tobacco

Next Safety, Inc. will begin to sample its proprietary pulmonary
device that has proven to have higher efficacy than cigarettes and
unlike tobacco products does not contain carcinogens. Tobacco is the
second leading cause of death globally; 600 million persons smoking
today will die prematurely from their habit.

The company will begin sampling devices to select reporters in
Boston on Tuesday, August 14th and Wednesday, August 15th; in
Washington D.C. on Thursday, August 16th and Friday August 17th; and
in New York on Monday, August 20th. In addition, the company will hold
a moderated discussion at the Mandarin Oriental in New York on
Tuesday, August 21st. Attendees will include: leading pulmonologists
and oncologists, reporters and public officials, as well as smokers
and non-smokers.

Next Safety moved into a new 32,000 square feet facility on July
27th. During the next eighteen months Next Safety expects to occupy
850,000 square feet of additional office/manufacturing space and hire
approximately 3,600 employees.